Results 121 to 130 of about 994,833 (202)

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas. [PDF]

Medicina (Kaunas), 2023
Aydin D, Kefeli U, Ozcelik M, Erdem GU, Sendur MA, Yildirim ME, Oven BB, Bilici A, Gumus M.   +8 more
europepmc   +1 more source

Prognostic value of metastatic lymph node ratio and its effect on disease-free survival in colon cancer. [PDF]

Front Oncol
Aslan O, Topcu R, Sezikli İ, Yüksek MA, Perçem AK, Uğur F.   +5 more
europepmc   +1 more source

Metastatic lymph node targeted CTLA4 blockade: a potent intervention for local and distant metastases with minimal ICI-induced pneumonia. [PDF]

J Exp Clin Cancer Res, 2023
Mishra R, Sukhbaatar A, Mori S, Kodama T.   +3 more
europepmc   +1 more source

Comparison of PD-L1 expression in head and neck squamous cell carcinoma among preoperative biopsy, surgical resection and metastatic lymph node. [PDF]

Front Oncol
Sohn H, Kim M, Kim SY, Sun DI, Lee YS.
europepmc   +1 more source

Effects of the Largest Metastatic Lymph Node Size on the Outcomes of Patients who Underwent Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. [PDF]

Sisli Etfal Hastan Tip Bul, 2022
Bozkurt E, Tufekci T, Sucu S, Bilgic C, Ozoran E, Ozata IH, Kaya M, Tellioglu G, Bilge O.   +8 more
europepmc   +1 more source

Pre-contrast hyperattenuating metastatic lymph node on computed tomography due to iodide accumulation in a dog with thyroid carcinoma. [PDF]

J Vet Med Sci
Lee SK, Baek SM, Park JK, Kang J, Jang M, Lee K.   +5 more
europepmc   +1 more source

Clinical significance of the largest histopathological metastatic lymph node size for postoperative course of patients undergoing surgery for gastric cancer. [PDF]

Front Surg, 2023
Omeroglu S, Gulmez S, Yazici P, Demir U, Guven O, Capkinoglu E, Uzun O, Senger AS, Polat E, Duman M.   +9 more
europepmc   +1 more source

Prostate Carcinoma Metastatic in Lymph Node [PDF]

, 2020
openaire   +1 more source

MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections. [PDF]

Breast Cancer (Dove Med Press)
Cong B, Martin TA, Cao X, Ruge FS, Li AX, Mansel RE, Wang Y, Jiang WG.   +7 more
europepmc   +1 more source

Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients. [PDF]

Nat Commun, 2022
Liu T, Liu C, Yan M, Zhang L, Zhang J, Xiao M, Li Z, Wei X, Zhang H.   +8 more
europepmc   +1 more source